148 related articles for article (PubMed ID: 23194786)
1. Preventive effects of rosuvastatin on atrial fibrillation: a meta-analysis of randomized controlled trials.
Liu T; Korantzopoulos P; Li L; Li G
Int J Cardiol; 2013 Sep; 167(6):3058-60. PubMed ID: 23194786
[No Abstract] [Full Text] [Related]
2. A meta-analysis of randomized head-to-head trials of atorvastatin versus rosuvastatin for reductions in C-reactive protein.
Takagi H; Umemoto T
Int J Cardiol; 2012 Jan; 154(1):78-81. PubMed ID: 22019059
[No Abstract] [Full Text] [Related]
3. Controlled Rosuvastatin Multinational Trial In Heart Failure (the positive negative trial).
Serebruany VL
Am J Cardiol; 2008 Jun; 101(12):1808-9. PubMed ID: 18549865
[No Abstract] [Full Text] [Related]
4. Rosuvastatin in patients with elevated C-reactive protein.
Pierard LA
N Engl J Med; 2009 Mar; 360(10):1040; author reply 1041-2. PubMed ID: 19271277
[No Abstract] [Full Text] [Related]
5. Atorvastatin, not rosuvastatin, improves cardiac function in heart failure: a meta-analysis of randomized trials.
Takagi H; Umemoto T
Int J Cardiol; 2012 Mar; 155(2):296-9. PubMed ID: 22200185
[No Abstract] [Full Text] [Related]
6. CORONA--rosuvastatin in older patients with systolic heart failure.
Jackson G
Int J Clin Pract; 2008 Jan; 62(1):1. PubMed ID: 18173807
[No Abstract] [Full Text] [Related]
7. The cost-effectiveness of rosuvastatin therapy JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
Hlatky M
J Am Coll Cardiol; 2011 Feb; 57(7):792-3. PubMed ID: 21310314
[No Abstract] [Full Text] [Related]
8. [The JUPITER study].
Gaspardone A; Maseri A
G Ital Cardiol (Rome); 2009 May; 10(5):267-70. PubMed ID: 19537439
[No Abstract] [Full Text] [Related]
9. The Post-JUPITER trial era and the cost of preventive medicine.
Papadopoulos VP
Hellenic J Cardiol; 2010; 51(2):187-8. PubMed ID: 20378525
[No Abstract] [Full Text] [Related]
10. JUPITER study highlights value of anti-inflammatory action of rosuvastatin.
Cardiovasc J Afr; 2009; 20(3):211. PubMed ID: 19575096
[No Abstract] [Full Text] [Related]
11. Rosuvastatin and cardiovascular continuum when time is important.
Barrios V; Escobar C
J Am Coll Cardiol; 2010 Apr; 55(15):1645-6; author reply 1646. PubMed ID: 20378088
[No Abstract] [Full Text] [Related]
12. High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial.
Peña JM; MacFadyen J; Glynn RJ; Ridker PM
Eur Heart J; 2012 Feb; 33(4):531-7. PubMed ID: 22187510
[TBL] [Abstract][Full Text] [Related]
13. [JUPITER study, more reason to give statins as preventive measure - commentary].
Narkiewicz K
Kardiol Pol; 2009 Mar; 67(3):346-7. PubMed ID: 19469067
[No Abstract] [Full Text] [Related]
14. Public health. U.S. panel favors wider use of preventive drug treatment.
Couzin-Frankel J
Science; 2010 Jan; 327(5962):130-1. PubMed ID: 20056859
[No Abstract] [Full Text] [Related]
15. Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure.
Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Gadaleta A; Frisardi V; Santamato A; Capurso A; Panza F
J Am Geriatr Soc; 2008 Jul; 56(7):1366-7. PubMed ID: 18774975
[No Abstract] [Full Text] [Related]
16. The Jupiter trial--new territory for statins?
Wheeler DC
Nephrol Dial Transplant; 2009 Jul; 24(7):2036-7. PubMed ID: 19541666
[No Abstract] [Full Text] [Related]
17. Rosuvastatin and progression of atherosclerosis.
Nicholls SJ
Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):925-33. PubMed ID: 18666843
[TBL] [Abstract][Full Text] [Related]
18. Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.
Maggioni AP; Fabbri G; Lucci D; Marchioli R; Franzosi MG; Latini R; Nicolosi GL; Porcu M; Cosmi F; Stefanelli S; Tognoni G; Tavazzi L;
Eur Heart J; 2009 Oct; 30(19):2327-36. PubMed ID: 19717850
[TBL] [Abstract][Full Text] [Related]
19. Letter by Wells and Eisenberg regarding article, "Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials".
Wells MT; Eisenberg T
Circulation; 2010 Dec; 122(23):e575; author reply e577. PubMed ID: 21135368
[No Abstract] [Full Text] [Related]
20. Effects of rosuvastatin on serum asymmetric dimethylarginine levels and atrial structural remodeling in atrial fibrillation dogs.
Li J; Xia W; Feng W; Qu X
Pacing Clin Electrophysiol; 2012 Apr; 35(4):456-64. PubMed ID: 22242708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
